Continue
By using our website you accept our cookies policy.Find out more

In vitro diagnostics for early detection of cancer

Posted on 30/05/2018

The Cancer Research UK Early Detection Team and KTN are holding a showcase/networking event focused on in vitro diagnostics on 13th July in London.

Earlier diagnosis of cancers would significantly improve survival rates of patients and could save the NHS vast amounts of money. However, the translation of novel cancer early detection diagnostics is challenging and has a high attrition rate.

Cancer Research UK recognises that increased collaboration between academia  (including clinicians), commercial researchers and industry will help facilitate and improve the translation of Early Detection Research.

The Early Detection Team at Cancer Research UK are therefore launching a number of networking events to help foster collaboration between industrial and academic researchers. The first meeting will be held in partnership with the Knowledge Transfer Network (KTN) on Friday 13 July, 10am-5pm, at British Medical Association (BMA) House, London.

The event will focus on Early Detection of Cancer (EDx) In Vitro Diagnostics and will be a catalyst for applications to Cancer Research UK’s new Primer Award, which offers up to £100,000 seed funding for novel ideas and new collaborations, with little to no preliminary research required.

The meeting will include presentations of other funding opportunities (including <£2.5 million for early detection research), plenary talks and sessions involving pairing of academic and industry researchers based on complementarity, as well as plenty of opportunity for networking.

You can find out more and express you interest in attending the Networking Event on Early Detection of Cancer In Vitro Diagnostics  on 13th July in London here.

You can find information on further funding opportunities for early detection research here.

Cancer Research UK are also hosting an Early Detection Innovation Sandpit event on 16th – 18th July 2018 in Oxfordshire, and an Early Detection of Cancer Conference on 2nd -4th October 2018 in Portland, Oregon.

Related Content

Shaping the future of precision medicine
KTN, on behalf of UK Research and Innovation, is holding a briefing event on 31 May in London for a new Collaborative R&D funding opportunity.
Boosting research efforts for coeliac disease
Coeliac UK's research fund aims to change the future for people with coeliac disease and gluten related autoimmune conditions.